Cold Genesys

Make payments with PayPal - it's fast, free and secure! Learn about supporting IT History Society
  • 2010

Company Description

Cold Genesys, Inc. (“CGI”) is a privately-held, clinical-stage oncolytic viral immunotherapy company

Cold Genesys, Inc. acquired the rights to develop CG0070 from BioSante Pharmaceuticals (Nasdaq: BPAX). A phase I/IIa dose escalating clinical trial has already completed in 35 patients with NMIBC. Cold Genesys is hopeful to get this therapy back into the clinical setting with the initiation of the proposed phase II/III trial.

CrunchBase
Edit this page
Add a company to our database